SCHEMBL17599523

SCHEMBL17599523

CCCCCC(Oc1cc(NS(=O)(=O)c2c(C)c(C)cc(C)c2C)c2ccccc2c1)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 4/20 0.45
▸ PPARA Q07869 3/20 0.45
▸ KDM4E B2RXH2 4/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ CRHBP P24387 1/20 0.43
▸ CRHR2 Q13324 1/20 0.43
▸ CTRC Q99895 1/20 0.42
▸ PTGES O14684 1/20 0.42
▸ ALOX5 P09917 1/20 0.42
▸ KEAP1 Q14145 6/20 0.40
▸ NFE2L2 Q16236 3/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ ALDH2 P05091 1/20 0.35
▸ PYGL P06737 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599529 0.92 KDM4E (0.41) PPARGPPARAKDM4EKMT2AMEN1
SCHEMBL17599536 0.79 KDM4E (0.47) KDM4EKMT2AMEN1ALDH1A1HPGD
SCHEMBL17599543 0.78 KDM4E (0.43) PPARGPPARAKDM4EKMT2AMEN1
SCHEMBL17614087 0.75 PPARG (0.57) PPARGPPARAKDM4EKMT2ACTRC
SCHEMBL17599531 0.73 KDM4E (0.44) KDM4EKMT2AMEN1ALDH1A1HPGD
SCHEMBL17599534 0.73 KDM4E (0.44) KDM4EKMT2AMEN1ALDH1A1HPGD
SCHEMBL17599533 0.73 KDM4E (0.44) KDM4EKMT2AMEN1ALDH1A1HPGD
SCHEMBL17614126 0.72 KDM4E (0.41) KDM4EKMT2AMEN1ALDH1A1HPGD
SCHEMBL28617984 0.72 PPARA (0.79) PPARGPPARACTRCPTGESALOX5
SCHEMBL17599535 0.71 KDM4E (0.53) KDM4EKMT2AMEN1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998292-A1 Naphthyl sulfonamide derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP claimed
EP-2998292-A1 Naphthyl sulfonamide derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
EP-2998292-A1 Naphthyl sulfonamide derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback